BRIACELL THERAPEUTICSCS CORP - WARRANT

Share · CA10778Y1126 · BCTXW (XNAS)

No Price

17.12.2025 20:38

Current Prices from BRIACELL THERAPEUTICSCS CORP - WARRANT

Exchange	Ticker	Currency	Last Trade	Price	Daily Change
NASDAQ	BCTXW	USD	17.12.2025 20:38	0,04 USD	0,0003 USD +0,69 %

Company Profile for BRIACELL THERAPEUTICSCS CORP - WARRANT Share

BriaCell Therapeutics Corp. operates as a Phase 3 biotechnology company transforming cancer care with its novel cellular immunotherapies. It is conducting a pivotal Phase 3 clinical trial in advanced breast cancer with its Bria-IMT in combination with an immune check point inhibitor. It is also developing personalized off-the-shelf treatments for breast cancer, prostate cancer, and other cancers. The company has a collaboration with Incyte Corporation to evaluate combination of the Bria-IMT. BriaCell Therapeutics Corp. is based in West Vancouver, Canada.

AI Analysis of BRIACELL THERAPEUTICSCS CORP - WARRANT

Click any analysis below to get instant AI insights from finAgent

Company Data

Name BRIACELL THERAPEUTICSCS CORP - WARRANT

Company BriaCell Therapeutics Corp.

Symbol BCTXW

Website https://briacell.com

Primary Exchange

NASDAQ

ISIN CA10778Y1126

Asset Class Share

Sector Healthcare

Industry Biotechnology

CEO William V. Williams FCPA,

Country Canada

Currency USD

Employees 0,0 T

Address Bellevue Centre, V7T 2X1 West Vancouver

IPO Date 2012-08-13

Ticker Symbols

Name	Symbol
NASDAQ	BCTXW

More Shares

Investors who hold BRIACELL THERAPEUTICSCS CORP - WARRANT also have the following shares in their portfolio:

EBRD 25/28 MTN Bond

Simtrol, Inc. Share

The financial platform MoneyPeak tracks and analyzes investments and portfolios. From securities portfolios to crypto purchases.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.

Imprint Data Protection Blog Community Feedback Changelog